Resource Center.  Learn more: acceess indepth product, service, and industry knowledge


Whitepaper & Case Study: Why CAPA Still Matters, and How a Major Medical Device Company Implemented a Successful System

Once again, the FDA's most common 483 observation cited for medical device manufacturers is the failure to maintain a proper Corrective and Preventive Action System (CAPA). In this updated white paper, you'll learn from former FDAers on how to properly implement an effective CAPA system and prepare for an FDA inspection. In addition, you will also read about how Bausch & Lomb successfully installed a worldwide CAPA system.

AssurX White Paper and Case Study: Why CAPA still matters and how a major medical device company implemented a successful system
This recently updated and revised whitepaper provides a comprehensive understanding of CAPA, along with a case study on what a successful CAPA implementation should look like. Request your copy today!

To request your paper, or any additional information, please fill out the form below.

* Denotes a required field

(Only corporate addresses
will be honored)

We're Ready to Help
Ask for information about AssurX QMS & Regulatory Compliance Software Solutions Now

Looking for Answers Now?
> Get More Info


Call Us Today


Send Us Email

Bookmark and Share

Follow Us: Twitter Blog